Survey on “β-Thalassaemia and Sickle Cell Disease.”

GermanOncology is currently conducting a survey on “ß-thalassaemia and sickle cell disease” among haematologists/oncologists in private practice, on behalf of an American biotech company. This survey aims to gain a better understanding of the patient flow among patients with thalassemia and sickle cell disease, and to understand the development of immigration to be able to place future, new treatment options for these diseases in the right place, as quickly as possible.

If you are a registered haematologist/oncologist involved in the treatment of patients with ß-thalassemia or sickle cell disease and would like to participate in the paid online survey, you may contact us via We will then get in touch with you and provide further details (e.g. amount of the payment, duration of the survey). You will not receive an individual link to the online questionnaire until you have definitely expressed your agreement to participate. If you decline to participate, your data will be deleted immediately, in accordance with the EU DSGVO.